DW-1350

• Description :

  DW-1350 is a LTB4 receptor antagonist.

• UNSPSC :

  12352005

• Target :

  Leukotriene Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/DW-1350.html

• Solubility :

  10 mM in DMSO

• Smiles :

  N=C(C1=CC=C(OCCCCCOC2=CC=C(C3=C(C(C)C)SC(C)=N3)C=C2)C=C1)NO

• Molecular Formula :

  C25H31N3O3S

• Molecular Weight :

  453.60

• References & Citations :

  [1]Kang JH, et al. 5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1expression. Bioorg Med Chem. 2015 Nov 1;23 (21) :7069-78.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  LTB4

• CAS Number :

  [491577-61-8]